Edition:
United Kingdom

People: Axsome Therapeutics Inc (AXSM.OQ)

AXSM.OQ on NASDAQ Stock Exchange Global Market

26.31USD
22 Jul 2019
Change (% chg)

$1.46 (+5.88%)
Prev Close
$24.85
Open
$25.10
Day's High
$26.85
Day's Low
$24.59
Volume
259,399
Avg. Vol
348,810
52-wk High
$27.99
52-wk Low
$1.94

Pizzie, Nick 

Mr. Nick Pizzie CPA is appointed as Chief Financial Officer of the company effective May 16, 2018. He was the Vice President and Chief Financial Officer of Pierre Fabre USA, the U.S. affiliate of Pierre Fabre, prior to joining the Company. Previously, he was Senior Finance Director at Immucor. Prior to Immucor, he held positions of increasing responsibility in finance and accounting at Merck and Pfizer. Mr. Pizzie began his career at Arthur Andersen, where he served as staff auditor. He earned his BS in Accounting, BA in Economics, and MBA in Finance, and Supply Side Logistics, from Rutgers University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --